AWARDS

GRANTS

Principal Investigator: John Fanton, MD
Project Name: Placebo vs. Extended Release Stimulant Crossover Trial in Preschoolers with ADHD
Sponsor: National Institute of Mental Health (NIMH)

Principal Investigator: Patrick Lee, MD
Project Name: A Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Study to Assess the Safety and Efficacy of Doripenem Compared With Imipenem in the Treatment of Subjects with Ventilator-Associated Pneumonia
Sponsor: Johnson & Johnson

Principal Investigator: John McCann, MD
Project Name: A Multi-Center Randomized Phase 2b Study of Cetuximab (Erbitux®) in Combination with Platinum-Based Chemotherapy as First Line Treatment of Patients with Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)– AC01L08 ACORN/ImClone/MedNet
Sponsor: ImClone Systems, Inc.

Principal Investigator: Alan Schneyer
Project Name: CEAR- Interdisciplinary Post Doc Award 2009
Sponsor: University of Massachusetts Amherst

Principal Investigator: Alan Schneyer
Project Name: Physiologic Roles of Activin and Myostatin Antagonists R01DK075058
Sponsor: University of Massachusetts Amherst

Principal Investigator: Howard Smithline, MD
Project Name: Efficacy of Intravenously Administered MEDI-563
Sponsor: MedImmune, Inc.

Principal Investigator: Howard Smithline, MD
Project Name: Pharmacokinetics of Oral Thiamine
Sponsor: Baystate Health, Inc.

Principal Investigator: Bruce Waslick, MD
Project Name: A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose Optimization Study Evaluating the Efficacy and Safety of SPD503 in Combination with Psychostimulants in Children and Adolescents Aged 6-17 with a Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)
Sponsor: Shire Development, Inc